Online registration for this event is now closed. If you would like to register for this event, please register onsite.
The DACC 2013 Spring Meeting will explore mechanisms of acute and chronic skeletal and cardiac injury, preclinical predictive assays, and models currently in use or being evaluated to reduce clinical skeletal and cardiac inury in late-stage clinical trials.
This meeting is sponsored by the AACC Animal Clinical Chemistry Division and is hosted and supported by the Drug Safety Department of Novartis Pharmaceutical Research & Development.